CD8A and cancer: CD8+ T-lymphocytes are preferred immune cells in cancer immunotherapy, and extensive research already has gone into PET imaging of cytotoxic human T cells, recently resulting in first-in-human imaging studies of anti-CD-8 imaging in patients with solid tumors (78).